Michael Ussery - 24 Feb 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
President & COO
Signature
/s/ R. Michael Ussery
Issuer symbol
NHC
Transactions as of
24 Feb 2025
Transactions value $
$0
Form type
4
Filing time
26 Feb 2025, 17:42:38 UTC
Previous filing
03 Jan 2025
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Common Stock 153K 24 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Award $0 +15K $0.00 15K 24 Feb 2025 Common Stock 15K $90.62 Direct F1, F2
holding NHC Option to Purchase Common Stock 4.23K 24 Feb 2025 Common Stock 4.23K $63.96 Direct
holding NHC Option to Purchase Common Stock 9K 24 Feb 2025 Common Stock 9K $53.94 Direct
holding NHC Option to Purchase Common Stock 13.5K 24 Feb 2025 Common Stock 13.5K $94.10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.